Latest News and Press Releases
Want to stay updated on the latest news?
-
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
-
Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains...
-
Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Asset Purchase Deals...
-
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
-
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market
-
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Tissue Clearing Market by Product, by Tissue Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
-
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
-
DALLAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- From January 20-23, 2025, North Texas took center stage as a global hub for innovation during Advanced Therapies Week (ATW) 2025. This signature event...
-
Northstrive Biosciences, a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservatio
-
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium